Halobacterium cutirubrum was cultured in a complex medium designed for extreme halophiles containing 4 M-NaCl in the absence or presence of bacitracin (7, 14 or 28 p~) with shaking at 37 "C for 24 h. Bacitracin at 7 or 14 p~ inhibited growth (50% and loo%, respectively), phospholipid synthesis (88 % and 96%, respectively) and bacterioruberin synthesis (65 % and 87%, respectively) relative to a control lacking bacitracin. After 5 h incubation in the presence of 7 or 28 pM-bacitracin, total lipid biosynthesis, as measured by incorporation of 14C from short-term labelling with [ 14C]glycerol, was inhibited by 26% and 66%, respectively. Bacitracin at 7 or 28 p~ inhibited biosynthesis of the major phospholipids (9% and 60%), glycolipids (25% and 85 %) and polyisoprenyl pyrophosphate (75 % at both concentrations). These results support the concept that polyisoprenyl pyrophosphate is involved directly in the biosynthesis of phospholipids, glycolipids and bacterioruberins in the extreme halophile H. cutirubrum.
INTRODUCTION
Bacitracin is a cyclic peptide antibiotic which has a strong inhibitory effect on the growth of eubacteria and archaeobacteria of the genus Halobacterium (Sievert & Strominger 1967 ; Mescher & Strominger, 1975) . This inhibition is attributed to its complexing with polyisoprenyl pyrophosphates which are involved in synthesis of peptidoglycans in eubacterial cell walls (Storm & Strominger, 1973) and presumably of glycoproteins in cell walls of halobacteria (Mescher et al., 1974) . In addition, bacitracin has been reported to inhibit phospholipid and glycolipid biosynthesis in the extremely halophilic Halobacterium cutirubrum (Basinger & Oliver, 1979) .
The extremely halophilic halobacteria have membrane phospholipids and glycolipids that are comprised of saturated phytanyl glycerol ether analogues of phosphatidylglycerophosphate (PGP), phosphatidylglycerosulphate (PGS), phosphatidylglycerol (PG) and a sulphated triglycosyl-C,,-diether (S-TGD) (Kamekura & Kates, 1988) . Recent biosynthetic studies have suggested that the biosynthetic pathways for these lipids involve formation of glycerol-etherlinked C,,-isoprenyl intermediates which are subsequently reduced to the final saturated lipids (Moldoveanu & Kates, 1988) . The primary precursors of these lipids are most likely to be the polyisoprenyl pyrophosphates, geranylgeranyl or phytyl pyrophosphates, rather than the saturated phytanyl pyrophosphate. Biosynthesis of bacterioruberins (Cso-carotenoids), the typical red pigments present in extreme halophiles, is also presumed to involve geranylgeranyl pyrophosphate as an intermediate (Kushwaha & Kates, 1979; Kushwaha et al., 1980) .
To obtain further evidence supporting the involvement of polyisoprenyl pyrophosphates in lipid synthesis in halobacteria, we have undertaken a study of the effect of bacitracin on the ~~ Abbreviations : PA, phosphatidic acid; PG, phosphatidylglycerol; PGP, phosphatidylglycerophosphate; PGS, phosphatidylglycerosulphate; S-TGD, sulphated triglycosyldiphytanylglycerol.
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biosynthesis of individual polar lipids and total bacterioruberins in H. cutirubrum. If isoprenyl pyrophosphates were the primary precursors of phospholipids and glycolipids then complexing these pyrophosphates with bacitracin should inhibit synthesis of the cellular lipids.
METHODS
Growth of H . cutirubrum in the presence of bacitracin and [ U-'4clglycerol. Cultures of H . cutirubrum were grown in 100 ml 'low-phosphate' medium containing 4 M-NaCl (Moldoveanu & Kates, 1988) , in the absence or presence of bacitracin (Sigma; 7, 14 or 28 PM) with shaking for 24 h. Growth was monitored by measurement of the optical density of the cultures at 660 nm and samples were removed at 0,4,8 and 24 h for protein analysis and at 0 and 24 h for lipid extraction. Bacteria were harvested by centrifugation at loo00 g, and the cell pellet was washed in basal salt solution (4 M-NaC1, 27 mM-KCl+ 80 m~-MgsO,) and resuspended in the same basal salt solution ; samples were then taken for protein analysis (Markwell et al., 1981) , and for lipid extraction as described below.
For lipid metabolism studies in the presence of [U-14C]glycerol, the cell culture in 100ml low-phosphate medium was preincubated (with or without bacitracin at 7, 14 or 28 PM) at 37 "C for 5 h (taken as zero time of labelling). An aqueous solution of [U-14C]glycerol containing 100 pCi total activity (specific activity of the Amersham product 45 Ci mol-l and of the Dupont product 10 Ci mol-l) (1 Ci = 37 GBq) was added and after incubation at 37 "C for a further 10, 15 or 30 min, the bacteria were harvested by centrifugation at 1Oo00g and their lipids extracted as follows.
Extraction of lipids, lipid analysis, and counting ofl4C. A suspension of each cell pellet in 4 M basal salt solution was extracted with methanol/chloroform (2 : 1, v/v) using the procedure of Bligh & Dyer (1959) , as modified by Kates (1986) . Suitable samples of the chloroform phase containing the total lipids were counted for 14C-radioactivity in Aquasol 2 (Dupont) by liquid scintillation counting and analysed for lipid phosphate by the modified microprocedure of Bartlett (Kates, 1986) .
Bacterioruberins. The content of total bacterioruberins in the total lipid extracts (chloroform phase) was measured spectrophotometrically using the absorption coefficient A Fm = 2540 at 490 nm (Kushwaha et al., 1974) .
Chromatography of total lipids. Total lipid was subjected tg thin-layer chromatography (TLC) on analytical precoated plates (Whatman K6 silica gel G, 0.25 mm thick) using double development in the solvent system CHCl,/methanol/acetic acid/H20 (85 : 22.5 : 10 : 4, by vol.). Radioactive spots were detected by autoradiography (Fuji X-ray film) and were scraped into scintillation vials and counted for 14C-radioactivity. The results are expressed as pCi of 14C incorporated into total lipid per 100ml of culture and as a percentage of the total radioactivity incorporated into each lipid component. Identification of labelled spots was based on TLC mobilities relative to authentic standards (Moldoveanu & Kates, 1988) .
RESULTS A N D DISCUSSION
Growth of H. cutirubrum in the presence of bacitracin, as followed by measurement of optical density at 660nm and protein content, depended on the concentration of bacitracin in the medium (Fig. 1) . After a lag period of 4 h, growth over a 24 h period was inhibited by 50% at 7 pM-bacitracin and was completely inhibited at 14 PM, as shown both by optical density and by protein measurements (Fig. 1) . At 28 pM-bacitracin, optical density values decreased below the initial control values (Fig. l) , which may be attributed to sphere formation (Mescher 8z Strominger, 1975) . However, the loss of protein at 28 pM-bacitracin (Fig. 1) is clearly indicative of cell lysis, since protein was determined on cell pellets spun down at lOOOOg.
At 7 pM-bacitracin, synthesis of bacterioruberin decreased over 24 h by 65% relative to the zero-bacitracin control; the synthesis of phospholipid decreased to an even greater extent (88 %).
At the same bacitracin concentration, protein synthesis and growth decreased by SO% (Fig. 1) . Thus, the relatively greater decrease in lipid synthesis compared to the decrease in growth induced by bacitracin (88 % vs 50%) is indicative of an inhibition of lipid synthesis per se and cannot be accounted for by the decrease in growth alone. The decrease in the amount of lipid-P per amount of cellular protein in cells grown for 24 h in 7 pM-bacitracin relative to control cells [2.05 vs 3.33 pg lipid-P (mg cell protein)-' is further indicative of inhibition of phospholipid synthesis. At the higher bacitracin concentration (14 PM), when growth and protein synthesis were 100 % inhibited, phospholipid synthesis was also almost completely inhibited (96%).
The effect of bacitracin on lipid biosynthesis was studied further by observing the changes in [ 14C]glycerol incorporation into total lipids during short-term labelling (15 min) after preincubation with 7 or 28 pM-bacitracin for 5 h. As shown in Table 1 , the presence of 7 p~-bacitracin in the growth medium for 5 h resulted in 26% inhibition of short-term (15 min) incorporation of [ 4C]glycerol into total lipids. This inhibition value has been corrected for decrease in cellular protein (i.e. decrease in growth) by expressing the 14C incorporation as nCi (mg protein)-', and therefore represents the actual inhibition of overall lipid synthesis. Similar inhibition (21 %) was observed after a 30 min labelling with [14C]glycerol (Table 1) . At 28 p~-bacitracin, a much higher inhibition (66%) of [14C]glycerol incorporation was observed in a short-term (10 min) incubation. The pattern of short-term labelling of the individual polar lipids, PGP, PGS, PG, PA and S-TGD and biosynthetic intermediates (spots 7,8,9 and 12; see Moldoveanu in the absence or presence of 7 pM-bacitracin is shown in Fig. 2 . Quantification of the changes in [ 14C]glycerol incorporation into lipids corrected for decrease in cellular protein, is given in Table  2 . In the presence of 28 pwbacitracin, there was a strong inhibition (75%) of 14C-labelling of the isoprenyl pyrophosphate (spots 1 and 2), the non-phosphorylated intermediate (spot 12) and PA; an even stronger inhibition (8597%) was observed for S-TGD and two of its intermediates (spots 7 and 8) ( Table 2 ; Fig. 2 ). However, inhibition of 14C-labelling of the major phospholipids, PGP, PGS and PG, was less pronounced (5640%). At 7 pl-bacitracin lower inhibitions were observed after 15 min incubation with [ 14C]glycerol for all components except isoprenyl pyrophosphate (spots 1 and 2) ( Table 2) . Similar results were obtained with 7 p~-bacitracin after 30 min incubation (results not shown). Stone & Strominger (1971) and Storm & Strominger (1973) have shown that bacitracin forms complexes with polyisoprenyl pyrophosphates (in the presence of divalent cations), thus preventing these intermediates from participating in the biosynthesis of glycosylated proteins and isoprenoids. In extreme halophiles the biosynthesis of the phytanyl glycerol analogues of phospholipids and glycolipids is entirely dependent on the mevalonate pathway (Kates & Kushwaha, 1978) , which would supply the polyisoprenyl pyrophosphate(s) presumably required for synthesis of the di-C20-isoprenyl glycerol ether intermediates of the phospholipids and glycolipids (Moldoveanu & Kates, 1988) .
The strong inhibition of labelling of polyisoprenyl pyrophosphate (spots 1 and 2) by bacitracin together with the inhibition of labelling of the major phospholipids (PG and PGP), of S-TGD and of the non-phosphorylated intermediate (spot 12) (see Table 2 ) thus supplies independent evidence that polyisoprenyl pyrophosphates are directly involved in the synthesis of the phytanyl glycerol ether analogues of phospholipids and glycolipids in extremely halophilic bacteria as proposed by Moldoveanu & Kates (1988) .
The strong inhibition of synthesis of bacterioruberins by bacitracin would also support the proposed biosynthetic pathway for these Cso-carotenoids, involving the participation of geranylgeranyl pyrophosphate (Kushwaha & Kates, 1979) .
The present results thus show that bacitracin, apart from inhibiting growth of H. cutirubrum cells, also inhibits polar lipid and Cso-carotenoid synthesis, presumably by preventing the key
